Status:
COMPLETED
Characterization of the "Transfusion-dependent Prediabetes" Using Continuous Glucose Monitoring
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Prediabetic State
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Dysglycemia is a frequent finding in transfusion-dependent thalassemia (TDT). The oral glucose tolerance test (OGTT) remains the only validated screening test, but the procedure is complex and time-co...
Detailed Description
The selection of patients took place randomly among adult patients suffering from transfusion-dependent thalassemia (TDT) belonging to the Pediatric Hematology and Oncology Unit of the AOU University ...
Eligibility Criteria
Inclusion
- They were affected by transfusion-dependent thalassemia (TDT)
- They had a history of at least 10 years of therapy with red blood cell transfusions (transfusion frequency less than one months) and iron chelation therapy
- They tested negative for diabetes mellitus screening tests (fasting glycemia, OGTT).
Exclusion
- Pregnancy
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT06533618
Start Date
July 1 2023
End Date
October 30 2023
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro di Diabetologia Pediatrica "G.Stoppoloni"
Naples, Italy, 80100